Emma Walmsley, GlaxoSmithKline CEO (GSK via investor day livestream)

Post-split GSK to ex­it mar­quee world HQ, blue­print­ing small­er cor­po­rate digs

Days af­ter Glax­o­SmithK­line un­veiled plans for a ma­jor down­siz­ing of its of­fice foot­print with plans to ex­it two icon­ic US sites, the phar­ma com­pa­ny shared that its world head­quar­ters is get­ting the same treat­ment ahead of its con­sumer health­care split.

Up­on sep­a­rat­ing from GSK in mid-2022, the new con­sumer health­care busi­ness is mov­ing out of the land­mark GSK House in Brent­ford, and in­vest­ing near­ly $164 mil­lion in­to its own, brand-new fa­cil­i­ty in Wey­bridge, the phar­ma said on Mon­day.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.